Career of breakthroughs in neuroimaging recognized with one of the nation’s highest honours
A career that took an uncharted trajectory has been recognized with the Order of Canada, one of the country’s top honours.
Category:
Published on: 30 Jun 2025
Scientists argue the criteria we use for diagnosing autism may need revision
Without clear and effective biological tests for autism based on genes, brain or blood measurements, diagnosis today still largely depends on clinical assessment. The standard way of doing this is by observing how the individual fits the criteria for autism listed in gold standard manuals like the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).
Category:
Published on: 26 Mar 2025
Free, online training program strengthens training and brings specialized care to communities across Quebec
A healthcare telementoring program housed at The Neuro and supported by the Transforming Autism Care Consortium (TACC) is expanding its reach after achieving designation as an ECHO Superhub. Under the direction of Julie Scorah, PhD, this milestone ensures that specialized knowledge reaches underserved communities.
Category:
Published on: 25 Mar 2025
Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD in the last quarter of 2024.
Category:
Published on: 18 Mar 2025
NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians
A project led by Ziv Gan-Or, MD, PhD, at The Neuro (Montreal Neurological Institute-Hospital) of McGill University and Martine Tétreault, PhD, at Université de Montréal has received more than $8 million to sequence the genomes of 8,700 people, to map the role of genetics in neurological disorders.
Category:
Published on: 18 Mar 2025
$400,000 will fuel public-private collaboration to discover new disease biomarkers
A new project co-led by Thomas Durcan, PhD, Director of The Neuro's Early Drug Discovery Unit, and overseen by Mathilde Chaineau, PhD, the EDDU’s program manager, will receive $400,000 in support from Génome Québec. In partnership with Nardin Nakhla and Armstrong Murira from the Montreal-based company Simmunome, Durcan and Chaineau will develop a computational model of amyotrophic lateral sclerosis (ALS) on which to test for new biomarkers and therapeutic targets.
Category:
Published on: 17 Mar 2025
Five clinicians and scientists at The Neuro have been awarded King Charles III Coronation Medals in recognition of their contributions to our understanding of neurological disease. The Coronation Medal commemorates the Coronation of His Majesty King Charles III as King of Canada. The medal is administered by the Chancellery of Honours at Rideau Hall.
Category:
Published on: 14 Mar 2025
Mapping immune cell diversity reveals dexamethasone’s impact on brain cancer immunotherapy
Swelling caused by brain cancer is a problem that can lead to serious side effects and even death. While controlling swelling is important, a new study shows that a commonly prescribed anti-swelling drug suppresses the immune system for weeks after dosage, inhibiting the body’s ability to fight the cancer.
Category:
Published on: 26 Feb 2025
Projects include important research on Parkinson’s, glioblastoma and dementia
Category:
Published on: 10 Feb 2025
Academic and industry scientists collaborate on a new method to characterize research antibodies
Category:
Published on: 18 Dec 2024
YCharOS antibody characterization platform addresses the “reproducibility crisis” in research
An innovative research project led by researchers at The Neuro has been awarded $1.5M by the Government of Quebec through CQDM.
YCharOS is an innovative platform led by neuroscientists Peter McPherson and Carl Laflamme that validates antibody reagents for human proteins.
Category:
Published on: 12 Nov 2024
$1M grant from The Weston Family Foundation will pave the way for earlier intervention in REM sleep behaviour disorder and Parkinson’s disease
REM sleep behaviour disorder (RBD) is an often debilitating condition that causes people to act out in their sleep, sometimes violently. What’s worse, people with the disorder often go on to develop Parkinson’s disease.
Category:
Published on: 8 Nov 2024
$1.14 million from CIHR will resolve treatment roadblocks for rare brain disorders
Gene therapy for rare neurological disorders will move one step forward thanks to a $1.14 million grant from the Canadian Institutes of Health Research (CIHR).
Category:
Published on: 23 Oct 2024
Thomas Durcan’s project will dissect the role of microglia in degenerative conditions, to identify new therapeutic strategies for Alzheimer's treatment
An innovative new program based at The Neuro has received $2.6 million from the CQDM and the Brain Canada Foundation.
Category:
Published on: 16 Oct 2024
MRI data from large sample shows increased whole-brain connectivity in people with a second language
Neuroplasticity is the brain’s ability to build connections within itself, adapting to the surrounding environment. The brain is most plastic in childhood, forming new pathways in reaction to stimuli such as language.
Category:
Published on: 11 Oct 2024
Pages
